Hong Kong Pharmaceuticals Stock News

Lepu Biopharma (SEHK:2157) just ticked off a key milestone, receiving its initial upfront licensing payment from Excalipoint after meeting deal conditions, a concrete step toward monetizing its CTM012 and CTM013 cancer assets. See our latest analysis for Lepu Biopharma. Despite today’s softer mood, with a negative 1 day share price return, Lepu Biopharma’s share price has still logged a triple digit year to date gain, while the 1 year total shareholder return, though strong, lags that surge...

Country Garden Services Holdings Company Limited recently reshaped its finance leadership, with long-time executive Huang Peng stepping down as chief financial officer on December 5, 2025 to focus on managing the Group’s incubation businesses while remaining executive president. The appointment of experienced capital markets professional Tian Tian as the new CFO brings a fresh financial management perspective drawn from roles across technology, healthcare, and new energy logistics. We will...

Earlier in December 2025, Dongfang Electric Corporation Limited secured a major order to supply core equipment for a 50MW combined-cycle power project in Zhambyl, Kazakhstan, underlining its role in gas turbine power generation. The deal spotlights how growing demand for gas-fired power to support AI data centers is opening new overseas growth avenues for the company. We’ll now examine how this new Kazakhstan order, tied to rising power needs from AI infrastructure, shapes Dongfang...

When you see that almost half of the companies in the Personal Products industry in Hong Kong have price-to-sales...

Earlier this month, Kuaishou Technology’s Kling AI unit released the Kling Video 2.6 Model, enabling simultaneous generation of visuals, voiceovers, sound effects, and ambient audio in Chinese and English for up to 10-second clips from text or image prompts. By collapsing traditionally separate video and audio workflows into a single one-click process, this upgrade could materially cut content production costs and broaden Kling’s appeal across advertising, social media, and e-commerce use...

Chi Ho Development Holdings Limited ( HKG:8423 ) shareholders would be excited to see that the share price has had a...

China Suntien Green Energy Corporation Limited ( HKG:956 ) shareholders might be concerned after seeing the share price...

As global markets navigate a landscape of interest rate adjustments and economic uncertainties, Asia's financial scene continues to capture attention with its diverse investment opportunities. Penny stocks, while often overlooked, represent a unique segment where smaller or newer companies can offer significant growth potential at lower price points. In this article, we explore several promising penny stocks in Asia that combine solid financial health with the potential for impressive returns.

Akeso has recently reported a series of oncology milestones, including FDA approval to start a global Phase III trial of cadonilimab in advanced HER2‑negative gastric cancer and new Phase II/III data on ivonescimab in triple‑negative breast cancer and squamous non‑small cell lung cancer. Together, these updates underscore Akeso’s push to position its bispecific antibodies as potential new standards of care across multiple solid tumors, supported by both efficacy and quality‑of‑life...

Key Insights Lingbao Gold Group's significant retail investors ownership suggests that the key decisions are influenced...

Earlier in December, Giant Biogene Holding announced a share repurchase plan, following recent analyst coverage from Citic Securities, Citi and UBS. The buyback move is being read as a signal of management confidence and a direct attempt to enhance shareholder value. With the share repurchase plan now in place, we’ll explore how this capital allocation decision shapes Giant Biogene’s broader investment narrative. AI is about to change healthcare. These 30 stocks are working on everything...

Key Insights Hysan Development's significant private companies ownership suggests that the key decisions are influenced...

It's not a stretch to say that Luk Fook Holdings (International) Limited's ( HKG:590 ) price-to-earnings (or "P/E...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

ASMPT Limited ( HKG:522 ), is not the largest company out there, but it received a lot of attention from a substantial...

Sunlight (1977) Holdings Limited ( HKG:8451 ) shareholders have had their patience rewarded with a 42% share price jump...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The Shandong Molong Petroleum Machinery Company Limited ( HKG:568 ) share price has fared very poorly over the last...

Viewing insider transactions for Longfor Group Holdings Limited's ( HKG:960 ) over the last year, we see that insiders...

The China Tianrui Automotive Interiors Co., LTD ( HKG:6162 ) share price has softened a substantial 27% over the...

Kinetic Development Group Limited ( HKG:1277 ) shares have retraced a considerable 25% in the last month, reversing a...

Wondering if Meituan is finally a bargain after years of volatility, or just another value trap in Chinese tech? This breakdown is designed to help you decide with a clear, valuation-led lens. The stock has inched up 2.2% over the last week even as it remains down 33.9% year to date and 37.3% over the past year, a combination that often signals shifting views on risk and long-term upside. Much of the recent movement has been shaped by ongoing headlines about China’s consumer recovery,...